Gene · 10818
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
| 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma. | Front Pharmacol | 2023 | 36895941 | PubTator, text mining | PubMed |
| Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review. | Transl Lung Cancer Res | 2023 | 36895930 | PubTator, text mining | PubMed |
| Display of multiple proteins on engineered canine parvovirus-like particles expressed in cultured silkworm cells and silkworm larvae. | Front Bioeng Biotechnol | 2023 | 36873345 | PubTator, text mining | PubMed |
| Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents. | RSC Adv | 2023 | 36865574 | PubTator, text mining | PubMed |
| Analysis Of Common Somatic Mutations In Colorectal Carcinoma And Associated Dysregulated Pathwaysarts. | J Ayub Med Coll Abbottabad | 2023 | 36849394 | PubTator, text mining | PubMed |
| Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma. | Cancer Res | 2023 | 36847778 | PubTator, text mining | PubMed |
| Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario. | Pharmaceutics | 2023 | 36839989 | PubTator, text mining | PubMed |
| The Landscape of Immunotherapy for Retroperitoneal Sarcoma. | Curr Oncol | 2023 | 36826126 | PubTator, text mining | PubMed |
| Aggressive High-grade Uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis. | Int J Gynecol Pathol | 2023 | 36811835 | PubTator, text mining | PubMed |
| How I treat endocrine-dependent metastatic breast cancer. | ESMO Open | 2023 | 36806375 | PubTator, text mining | PubMed |
| SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression. | Front Oncol | 2023 | 36776333 | PubTator, text mining | PubMed |
| Pediatric dermatofibrosarcoma protuberans: A clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China. | Front Oncol | 2023 | 36776313 | PubTator, text mining | PubMed |
| The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer. | Int J Mol Sci | 2023 | 36768298 | PubTator, text mining | PubMed |
| Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability. | Proc Natl Acad Sci U S A | 2023 | 36745784 | PubTator, text mining | PubMed |
| Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers. | Front Genet | 2023 | 36741322 | PubTator, text mining | PubMed |
| Bile acids as modulators of gut microbiota composition and function. | Gut Microbes | 2023 | 36740850 | PubTator, text mining | PubMed |
| Spatially constrained gene regulation identifies key genetic contributions of preeclampsia, hypertension, and proteinuria†. | Biol Reprod | 2023 | 36738257 | PubTator, text mining | PubMed |
| Genomic landscape of 891 RET fusions detected across diverse solid tumor types. | NPJ Precis Oncol | 2023 | 36690680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10818/papers?page=8